Physician profile
Marc Schecter
NPI 1811925167
$10,731.83
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.80 · 2021: $23.02 · 2022: $1,099 · 2023: $9,500 · 2024: $17.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,680 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $645 · Travel and Lodging: $140 · Food and Beverage: $52.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,680.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $645.00 |
| Travel and Lodging | $140.00 |
| Food and Beverage | $52.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,881.49 | 2022-2023 | Ofev |
| Mannkind Corporation | $645.00 | 2023 | Afrezza |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Gilead Sciences, INC. | $72.69 | 2022 | |
| Genentech USA, INC. | $23.02 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Schecter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.